Moleculin Biotech, Inc. (NASDAQ:MBRX) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Greetings, and welcome to the Moleculin Biotech Third Quarter 2023 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded. At this time, I’d like to turn the call over to Jenene Thomas, Investor Relations. Thank you. You […]
Operator: Greetings, and welcome to the Moleculin Biotech Third Quarter 2023 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Moleculin Biotech (MBRX) presents positive Phase 1B/2 clinical trial evaluating Annamycin streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Live video webcast with Walter Klemp, CEO and Jonathan Foster, Executive VP and CFO of Moleculin on Tuesday, October 25th at 12:00 PM ET
HOUSTON, Oct. 11, 2023 /PRNewswire/ Moleculin Biotech,.